Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Capital Expenditures (2021 - 2023)

P3 Health Partners (PIII) has disclosed Capital Expenditures for 4 consecutive years, with -$1.7 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Capital Expenditures changed N/A year-over-year to -$1.7 million, compared with a TTM value of -$464000.0 through Dec 2024, changed N/A, and an annual FY2023 reading of $1.8 million, down 18.18% over the prior year.
  • Capital Expenditures was -$1.7 million for Q3 2024 at P3 Health Partners, down from $1.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.2 million in Q2 2021 and bottomed at -$1.7 million in Q3 2024.
  • Average Capital Expenditures over 4 years is $502090.9, with a median of $656177.0 recorded in 2021.
  • The sharpest move saw Capital Expenditures crashed 57.3% in 2022, then soared 126.72% in 2023.
  • Year by year, Capital Expenditures stood at $299870.0 in 2021, then tumbled by 116.67% to -$50000.0 in 2022, then skyrocketed by 2476.0% to $1.2 million in 2023, then tumbled by 239.06% to -$1.7 million in 2024.
  • Business Quant data shows Capital Expenditures for PIII at -$1.7 million in Q3 2024, $1.2 million in Q2 2023, and $464000.0 in Q1 2023.